Ludwig Enterprises, Inc. (LUDG)
PNK · Healthcare · Medical Devices
Closing price as of 2026-09-10 · Source: TEK2day Finance
Key Metrics
About Ludwig Enterprises, Inc.
Ludwig Enterprises, Inc. operates as a genomic technology focused on developing testing approaches for inflammation-related chronic diseases, including cancers in the United States. The company integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits for cancer identification. It offers mRNA-based screening to provide early insights of potential health risks. The company develops Revealia Breast test, a non-invasive cheek swab screening kit designed to identify and analyze molecular signatures in mRNA expression associated with inflammation-related biological processes associated with the presence of breast cancer. Ludwig Enterprises, Inc. was founded in 1988 and is based in Miami, Florida.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | ||||
| Operating Income | (586K) | (371K) | (293K) | (565K) |
| Net Income | (649K) | 31K | (1.1M) | 219K |
| Diluted EPS | $0.00 | $0.00 | N/A | $0.00 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 217.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | ||
| Operating Income | (561K) | (1.4M) | (1.3M) | (1.8M) |
| Net Income | (965K) | (2.5M) | (3.0M) | (2.2M) |
| Diluted EPS | $-0.00 | $-0.01 | $-0.02 | $-0.01 |